- Transcript 'Cisavi.CG.ENS81.R268...' >
- Transcript 'KH2012:KH.C1.404.v1....' >
- Transcript 'Cisavi.CG.ENS81.R268...' >
- Transcript 'Boschl.CG.Botznik201...' >
- Transcript 'Cisavi.CG.ENS81.R268...'
Transcript Model
Transcript Id
Cisavi.CG.ENS81.R268.26467-40023.20147.t
Possible name(s)
EPHA4; EPHA7; EPHB2
Gene model
Location
R268 [28,803 / 39,951]
Amino acid sequence
Length: 959
>Cisavi.CG.ENS81.R268.26467-40023.20147.p
LMDTRTAISDVGWAMSPGSDWNEASVTHPDGSDRRMLMVCQIKKAHQNNWARTPYIPVNG
AQPLQHLINAIISILVYNRSCEDVPNVATCKETFNLYYYETDRDEATLFPPWREGTYIKV
DTIAADKRFGPGSKETNFETRDIGPLTKRGIYLAIQDTGACMALMHVRVYYKYCGPTEKN
LAFFQRTIAGPYMSSLEETNGTCVVNSIPDNGERATLRCNSEGEWIVPKGSCLCFPWLPQ
YNTEHPECGRGHYKSSVGNRACRMCPAYSDTRDYGSTECQCMQGYYRALSDDASMPCTKP
PSRPVNLHAVVNQTTARLSWERPYNDGGRDDLTYRIECMRCQAGFLACGPCEDGVDYKPR
QTNIAVTNVLVRDLSAYAYYKFKVFALNGASWVAQLDPAEADVNVETNEAVPTMVLGLRV
SEVSQTEVLLTWNNPEKMNGKIRQYEVSLDLINLMGEVLYMNLLNTTTKRSMRITGLKEN
SVYAVKVRASTDAGYGPYSVPLKFSPLASTTPAPKTSADHVGTIQIIVAVIAGFCIVVAI
MLIVFCCRRKSQKHKSKLDLEKVPMFVMGHVKNGTLSYIPSHKTYIDPTTYEDPARAVLD
FTKEIEASYVAIEEVIGGGEFGEVCLGRMRSPNTKNETDVAIKTLKSGYSTQQKLDFLGE
ASIMGQFDHPNVIRLEGVVTKSQPHMIITEFMENGSLDTFLRKRDGEFTVIQLVGILRNI
AAGMKYLSDMGYVHRDLAARNILVNAQLICKVSDFGLSRVLEESSDSTYTTRGGKIPIRW
TAPEAITYRKFTSASDVWSYGIVMWEVMSYGERPYWGMSNQDVIHAVGTGYRLPAPMDCP
QVQHKLMLDCWKKDRNERPKFGQVVASLDRMIREPEQLKAIAGHNPDRTTSLLRNHSIPS
SLGVWLDSIGIGGCKEKLLSAGYLTLDQILQISPSDLERLGITDMNQQNIVMESICNIK
Nucleotide sequence
Length: 2,877
>Cisavi.CG.ENS81.R268.26467-40023.20147.t
CTGATGGACACCAGAACAGCAATATCAGACGTTGGTTGGGCAATGTCACCAGGCTCTGAC
TGGAATGAAGCTAGCGTAACGCATCCTGACGGAAGCGACAGACGTATGCTGATGGTGTGC
CAGATTAAAAAGGCACATCAGAACAACTGGGCACGCACTCCTTACATCCCAGTGAACGGC
GCCCAGCCGTTGCAACATCTAATAAATGCTATCATTTCCATTCTTGTGTATAACAGATCA
TGCGAAGACGTCCCTAACGTGGCCACTTGCAAGGAAACCTTTAATCTGTACTACTATGAG
ACTGACAGAGACGAAGCAACCCTTTTCCCACCCTGGAGAGAGGGGACTTATATAAAGGTT
GACACGATTGCAGCAGACAAAAGATTTGGGCCCGGCTCAAAGGAAACTAACTTTGAAACA
AGAGACATTGGACCTTTAACAAAGCGAGGGATATATCTTGCTATCCAGGACACTGGTGCA
TGCATGGCACTTATGCACGTCCGTGTATATTATAAATACTGCGGACCAACCGAGAAAAAC
TTGGCGTTTTTCCAAAGAACGATTGCAGGACCATACATGTCTTCTTTGGAAGAAACGAAC
GGAACGTGCGTCGTAAACTCTATACCGGACAACGGCGAGAGAGCGACACTGAGGTGCAAC
AGCGAAGGGGAATGGATTGTACCCAAAGGCTCCTGTCTGTGCTTTCCGTGGCTTCCACAA
TACAACACCGAGCATCCGGAATGCGGACGAGGACACTACAAATCAAGCGTGGGGAATCGT
GCTTGCAGAATGTGTCCTGCTTACAGCGATACAAGAGATTACGGCTCAACTGAATGTCAG
TGTATGCAGGGTTATTATAGAGCACTCTCTGACGATGCATCTATGCCGTGCACGAAACCT
CCGAGCCGACCAGTAAACTTGCACGCAGTTGTGAATCAAACAACAGCAAGACTTTCATGG
GAACGGCCTTACAATGATGGCGGTCGTGATGATCTAACCTACAGAATTGAATGCATGAGA
TGTCAAGCTGGATTTCTTGCTTGTGGCCCGTGTGAGGATGGGGTGGACTACAAGCCCAGG
CAGACGAACATCGCTGTAACCAATGTCCTTGTACGGGACCTCAGTGCATACGCATATTAC
AAATTCAAGGTATTTGCATTGAACGGTGCAAGTTGGGTGGCGCAATTGGATCCTGCTGAA
GCCGATGTTAATGTCGAAACAAACGAAGCAGTTCCAACGATGGTTCTCGGCTTAAGAGTG
TCAGAAGTGTCTCAAACTGAAGTTCTACTGACATGGAATAATCCCGAAAAAATGAACGGC
AAGATAAGGCAATATGAAGTATCTCTTGATTTGATTAATCTGATGGGAGAAGTTCTGTAT
ATGAACTTGCTGAACACAACAACCAAGAGAAGCATGCGAATCACTGGATTAAAGGAGAAT
AGCGTTTATGCTGTCAAGGTTCGAGCGAGTACAGATGCAGGCTACGGACCGTACAGTGTG
CCACTTAAATTTAGCCCGCTTGCTTCAACTACCCCTGCTCCCAAAACATCTGCTGATCAC
GTGGGTACGATCCAAATCATCGTTGCGGTCATTGCTGGGTTTTGTATCGTCGTTGCAATA
ATGCTCATCGTGTTTTGTTGCAGAAGAAAATCTCAAAAACACAAATCGAAACTCGATTTG
GAAAAAGTCCCCATGTTTGTAATGGGTCACGTGAAGAACGGCACATTGAGCTATATTCCC
AGTCATAAAACGTATATAGACCCAACCACATATGAAGATCCCGCCAGAGCTGTTCTTGAT
TTTACAAAGGAAATTGAAGCATCATATGTCGCTATAGAAGAAGTAATAGGTGGAGGAGAG
TTCGGGGAAGTGTGTCTTGGTCGGATGAGATCACCAAACACCAAAAATGAAACCGATGTT
GCTATCAAGACCCTCAAAAGCGGCTACAGTACCCAACAGAAGTTGGATTTTCTTGGCGAA
GCGTCCATCATGGGACAGTTCGACCATCCTAATGTAATAAGATTGGAAGGAGTTGTCACG
AAGAGTCAGCCGCATATGATAATTACTGAGTTCATGGAGAACGGTTCGTTGGATACATTT
TTGAGAAAACGTGACGGCGAATTCACGGTGATACAGTTGGTTGGCATTCTTCGTAACATC
GCTGCTGGGATGAAATATTTGTCCGATATGGGTTATGTTCATCGGGATCTTGCAGCTAGG
AATATCCTCGTCAACGCTCAACTCATTTGCAAGGTTTCCGACTTCGGTTTAAGTCGTGTA
CTGGAAGAGAGCTCGGATTCGACGTACACAACTCGGGGTGGAAAGATTCCAATTCGATGG
ACGGCACCAGAAGCCATTACTTACCGGAAGTTTACGTCAGCAAGTGACGTATGGAGTTAT
GGTATTGTGATGTGGGAGGTGATGTCATACGGTGAAAGACCTTACTGGGGAATGTCAAAT
CAAGATGTTATTCATGCTGTTGGAACAGGGTATCGCTTACCAGCCCCCATGGACTGTCCG
CAAGTGCAGCACAAATTGATGTTGGATTGCTGGAAAAAGGATAGAAACGAGCGGCCCAAG
TTTGGTCAAGTGGTGGCGTCTTTAGATCGGATGATACGAGAGCCCGAACAACTGAAAGCG
ATCGCAGGGCACAACCCTGATCGAACCACGTCATTATTGCGTAATCACTCAATTCCGTCA
TCTCTGGGTGTGTGGTTGGACAGTATTGGTATCGGAGGTTGTAAAGAAAAGTTGCTTTCG
GCCGGTTATTTAACTCTAGATCAAATTCTGCAAATATCACCAAGCGACCTCGAGCGGTTA
GGAATAACCGACATGAACCAACAAAACATTGTGATGGAAAGCATCTGCAACATTAAA
| ProSiteProfiles |
Ephrin_rcpt_lig-bd_dom (IPR001090) - T[1-179] 50.493 |
| SMART |
Ephrin_rcpt_lig-bd_dom (IPR001090) - T[1-174] 2.7E-55 |
| SUPERFAMILY |
Galactose-bd-like_sf (IPR008979) - T[1-172] 2.34E-49 |
| Pfam |
Ephrin_rcpt_lig-bd_dom (IPR001090) - T[1-174] 2.3E-57 |
| Gene3D |
Galactose-bd-like_sf (IPR008979) - T[1-175] 3.3E-51 |
| PIRSF |
Tyr_kinase_ephrin_rcpt (IPR016257) - T[1-959] 0.0 |
| ProSiteProfiles |
FN3_dom (IPR003961) - T[300-410] 13.507 - T[414-513] 18.383 |
| SUPERFAMILY |
FN3_sf (IPR036116) - T[300-505] 1.52E-32 |
| Gene3D |
Ig-like_fold (IPR013783) - T[300-409] 9.6E-23 - T[411-523] 6.9E-18 |
| CDD |
FN3_dom (IPR003961) - T[301-392] 2.35624E-9 - T[412-504] 3.06893E-14 |
| SMART |
FN3_dom (IPR003961) - T[301-393] 3.3E-7 - T[412-496] 9.7E-9 |
| Pfam |
FN3_dom (IPR003961) - T[303-391] 1.4E-8 - T[417-499] 5.6E-12 |
| Pfam |
Eph_TM (IPR027936) - T[526-607] 2.8E-20 |
| SUPERFAMILY |
Kinase-like_dom_sf (IPR011009) - T[607-888] 8.06E-81 |
| ProSiteProfiles |
Prot_kinase_dom (IPR000719) - T[610-872] 38.025 |
| SMART |
Tyr_kinase_cat_dom (IPR020635) - T[610-868] 1.7E-133 |
| Pfam |
Ser-Thr/Tyr_kinase_cat_dom (IPR001245) - T[611-868] 1.6E-95 |
| ProSitePatterns |
Protein_kinase_ATP_BS (IPR017441) - T[616-643] . |
| PRINTS |
Ser-Thr/Tyr_kinase_cat_dom (IPR001245) - T[689-702] 2.3E-35 - T[726-744] 2.3E-35 - T[776-786] 2.3E-35 - T[795-817] 2.3E-35 - T[839-861] 2.3E-35 |
| ProSitePatterns |
Tyr_kinase_AS (IPR008266) - T[732-744] . |
| SUPERFAMILY |
SAM/pointed_sf (IPR013761) - T[895-955] 1.06E-10 |
| Pfam |
SAM (IPR001660) - T[900-957] 2.5E-8 |
| ProSiteProfiles |
SAM (IPR001660) - T[905-959] 12.044 |
| Protein Name | Identity | Bit Score | e-value |
|---|---|---|---|
| EPHA4_HUMAN | 47.988 % | 867 | 0 |
| EPHA7_HUMAN | 48.255 % | 860 | 0 |
| EPHA5_HUMAN | 46.573 % | 858 | 0 |